We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome

This study has been terminated.
(Unable to recruit sufficient number of participants)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00839501
First Posted: February 9, 2009
Last Update Posted: January 20, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Office of Rare Diseases (ORD)
Rare Diseases Clinical Research Network
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
Robert Griggs, MD, University of Rochester
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)